Quest Diagnostics Incorporated logo
DGXQuest Diagnostics Incorporated

Dividends

Dividend payments are $3.26 per share, with a current dividend yield of 1.58%. The company has dividend history for 14 consecutive years.

DGX Dividend Summary

Consecutive Years

14

Next Ex-Dividend Date

Jul 8, 2026

Next Payment Date

Jul 22, 2026

DGX Dividends per Share (Nominal History)

View full nominal table list

This step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency.

DGX Dividends CAGR Chart

Quest Diagnostics Incorporated (DGX)

Annual Dividend History

YearDividend/ShareYoY Growth
2026(YTD)$2.52
2025$3.15+6.42%
2024$2.96+6.09%
2023$2.79+7.31%
2022$2.60+7.44%
2021$2.42+9.50%
2020$2.21+4.25%
2019$2.12+8.72%
2018$1.95+8.33%
2017$1.80+13.92%
2016$1.58+7.48%
2015$1.47+13.95%
2014$1.29+7.50%
2013$1.20+76.47%
2012$0.68+70.00%
2011$0.40+0.00%
2010$0.40+0.00%
2009$0.40+0.00%
2008$0.40+0.00%
2007$0.40+2.56%

Quarterly Dividend History

QuarterDividend/ShareYoY Growth
Q3 2026$0.86+7.50%
Q2 2026$0.86+7.50%
Q1 2026$0.80+6.67%
Q4 2025$0.80+6.67%
Q3 2025$0.80+6.67%
Q2 2025$0.80+6.67%
Q1 2025$0.75+5.63%
Q4 2024$0.75+5.63%
Q3 2024$0.75+5.63%
Q2 2024$0.75+5.63%
Q1 2024$0.71+7.58%
Q4 2023$0.71+7.58%
Q3 2023$0.71+7.58%
Q2 2023$0.71+7.58%
Q1 2023$0.66+6.45%
Q4 2022$0.66+6.45%
Q3 2022$0.66+6.45%
Q2 2022$0.66+6.45%
Q1 2022$0.62+10.71%
Q4 2021$0.62+10.71%
Q3 2021$0.62+10.71%
Q2 2021$0.62+10.71%
Q1 2021$0.56+5.66%
Q4 2020$0.56+5.66%

Dividend Yield Metrics

Current Yield
1.58%
Average Yield (TTM)
1.58%
Average Yield (3Y)
1.44%
Forward Yield on Cost (3Y)
2.06%
Forward Yield on Cost (5Y)
2.45%
Forward Yield on Cost (10Y)
3.81%

Payout Ratio Analysis

Payout Ratio (Current)
36.02%
FCF Payout Ratio
27.29%
Payout Ratio (3Y Avg)
36.74%
Payout Ratio (5Y Avg)
31.49%
FCF Payout (3Y Avg)
32.68%
FCF Payout (5Y Avg)
27.50%

Dividend Coverage

Payout Ratio
36.0%
Dividends / net income
FCF Payout Ratio
27.3%
Dividends / free cash flow
Consecutive Years
14 years
Years with regular dividend payments
5Y Dividend Growth
7.3%
Compound annual dividend growth

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Secaucus, NJ
55,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis